Insiders who reported open-market trades in the last 12 months at the companies Todd Harris files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Todd Harris is a corporate insider, tracked as President and CEO, Director of Tyra Biosciences, Inc. (TYRA). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Todd Harris submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Todd Harris been buying or selling stock?
Recorded transactions: 0 open-market purchases and 10 open-market sales ($3.24M) across all tracked filings.
Todd Harris is President and CEO, Director of Tyra Biosciences, Inc. (TYRA). 7 SEC Form 4 filings on record going back to 2024, most recently on 17 September 2026. Most recent open-market trade: sold $371K of TYRA on 22 October 2024. Lifetime open-market sales: $3.24M.
Recent transactions
13
The latest 13 SEC Form 4 transactions reported by Todd Harris.
InsiderAlpha's records for Todd Harris go back to 2024: 7 primary Form 4 filings, an average of 2.3 per year. 10 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
